EN
HI
Asston Pharmaceuticals Chart
Asston Pharmaceuticals Share Key Metrics
Volume
0.00
Market Cap
62.15 CR
LTQ@LTP
0@73.01
ATP
0
Var Margin
53.5 %
Circuit Range
58.41-87.61
Delivery %
- %
Value
0.00
ASM/GSM
No
Market Lot
1000
Summary
Asston Pharmaceuticals share price is ₹73.01 as of 2 Jun, 2026. The stock Asston Pharmaceuticals intraday movement has stayed between ₹00 and ₹00, while on a 52-week basis,Asston Pharmaceuticals price 52 week high is ₹126.00 & its 52 week low is ₹65.20.
In terms of trading activity, Asston Pharmaceuticals has recorded a volume of 0 shares, The Asston Pharmaceuticals has a market cap of ₹8512360 CR. The stock’s Average Traded Price (ATP) stands at ₹0.00, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 0 @ ₹73.01.
Asston Pharmaceuticals operates within a circuit range of ₹58.41 – ₹87.61, with a Value of ₹0.00. The Delivery Percentage for the day is -1%. Additionally, Asston Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1000.
Asston Pharmaceuticals Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.94
Sector P/B
2.97
Sec. Div. Yield
0.55
Asston Pharmaceuticals Resistance and Support
Pivot 73.67
Resistance
First Resistance
74.33
Second Resistance
75.66
Third Resistance
76.32
Support
First Support
72.34
Second Support
71.68
Third Support
70.35
Asston Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-29 | Audited Results |
| 2026-03-30 | Notice of EGM & Others |
| 2026-02-07 | Raising of Funds |
| 2026-01-05 | Others |
| 2025-11-14 | Half Yearly Results |
| 2025-10-16 | Others |
| 2025-08-25 | A.G.M. |
Asston Pharmaceuticals News
Asston Pharmaceuticals Ltd - 544445 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th May, 2026
Asston Pharmaceuticals Board approved audited financial results for FY26. Revenue reached ₹25.47 crores, marking a 1.7% increase YoY, while net profit was ₹3.87 crores, up 0.3% YoY. Basic EPS for the year stood at ₹4.92.
May 29 2026 21:47:02
Asston Pharmaceuticals Ltd - 544445 - Board Meeting Intimation for Approving Audited Financial Ressults
Asston Pharmaceuticals' Board of Directors will convene on May 29, 2026, at 3:00 P.M. to consider and approve the audited financial results for Q4 FY26 and the full financial year. They will also address the statement of deviation of funds.
May 21 2026 20:49:43
Asston Pharmaceuticals Management
| Name | Position |
|---|---|
| Ashish Narayan Sakalkar | Managing Director |
| Saili Jayaram More | Whole Time Director & Chief Executive Officer |
Asston Pharmaceuticals Similar Stocks
Asston Pharmaceuticals FAQs
The Buying Price of Asston Pharmaceuticals share is 73.01 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Asston Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Asston Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Asston Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Asston Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Asston Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.
The Market Cap of Asston Pharmaceuticals is 62.15 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Asston Pharmaceuticals share price is 126.00 & 65.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Asston Pharmaceuticals belongs to the Healthcare sector.
